Medical Developments International Limited Provides Earnings Guidance for the Fiscal Year 2022 and Revenue Guidance for the Fiscal Year 2023
MVP's strong revenue growth trajectory is expected to continue into fiscal year 2023, driven by: significant growth in France; penetration in Australian hospital emergency departments; continued growth in Australian ambulance market; further market share gains in Respiratory segment, primarily in the US; volume growth in distributor markets driven by enhanced distributor engagement; and higher average selling prices driven by growth in direct sales.